Sirona Biochem Corp. (CVE:SBM – Get Free Report)’s stock price dropped 18.8% on Tuesday . The company traded as low as C$0.07 and last traded at C$0.07. Approximately 112,944 shares changed hands during mid-day trading, an increase of 44% from the average daily volume of 78,445 shares. The stock had previously closed at C$0.08.
Sirona Biochem Price Performance
The stock has a 50-day moving average of C$0.07 and a two-hundred day moving average of C$0.06. The company has a current ratio of 0.34, a quick ratio of 2.41 and a debt-to-equity ratio of 219.21. The firm has a market cap of C$16.69 million, a price-to-earnings ratio of -6.50 and a beta of -0.03.
Sirona Biochem Company Profile
Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program.
See Also
- Five stocks we like better than Sirona Biochem
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Top 3 Reasons to Invest in This Bond ETF for Stability and Growth
- 3 Healthcare Dividend Stocks to Buy
- 2 Drone Stocks Surging from Increased Media Attention
- Consumer Discretionary Stocks Explained
- Ciena Rebounds: AI and Strong Guidance Drive Post-Earnings Surge
Receive News & Ratings for Sirona Biochem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sirona Biochem and related companies with MarketBeat.com's FREE daily email newsletter.
